Cigna Files 8-K for Administrative Update, No New Financials

TL;DR

**Cigna's 8-K is a routine administrative update, nothing new for traders.**

AI Summary

The Cigna Group filed an 8-K on January 31, 2024, to report an 'Other Event' and 'Financial Statements and Exhibits.' This filing primarily serves to update administrative details, including its incorporation in Delaware and its main business address at 900 Cottage Grove Road, Bloomfield, Connecticut. For investors, this filing is largely procedural and doesn't contain new financial or operational news, meaning it has minimal direct impact on the stock's immediate valuation or outlook.

Why It Matters

This filing is largely administrative, confirming Cigna's corporate details and stock exchange listing, and does not contain new financial or operational information that would typically move the stock.

Risk Assessment

Risk Level: low — This 8-K filing is purely administrative and does not introduce any new financial, operational, or legal risks to the company.

Analyst Insight

Smart investors would note this as a routine administrative filing and not expect any immediate stock price movement or significant new information from it. Focus should remain on future earnings reports or material event filings.

Key Players & Entities

• The Cigna Group (company) — registrant of the 8-K filing
• Delaware (company) — state of incorporation for The Cigna Group
• New York Stock Exchange, Inc. (company) — exchange where Cigna's Common Stock is registered
• CI (company) — trading symbol for Cigna's Common Stock
• 900 Cottage Grove Road, Bloomfield, Connecticut 06002 (company) — principal executive offices address

FAQ

From the Filing

0000950159-24-000025.txt : 20240131 0000950159-24-000025.hdr.sgml : 20240131 20240131081229 ACCESSION NUMBER: 0000950159-24-000025 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240131 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240131 DATE AS OF CHANGE: 20240131 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cigna Group CENTRAL INDEX KEY: 0001739940 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 824991898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38769 FILM NUMBER: 24580694 BUSINESS ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 BUSINESS PHONE: 8602266000 MAIL ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 FORMER COMPANY: FORMER CONFORMED NAME: Cigna Corp DATE OF NAME CHANGE: 20181221 FORMER COMPANY: FORMER CONFORMED NAME: Halfmoon Parent, Inc. DATE OF NAME CHANGE: 20180508 8-K 1 cigna8k.htm THE CIGNA GROUP FORM 8-K false 0001739940 0001739940 2024-01-31 2024-01-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 31, 2024 The Cigna Group (Exact name of registrant as specified in its charter) Delaware 001-38769 82-4991898 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)   900 Cottage Grove Road Bloomfield , Connecticut 06002 (Address of principal executive offices) (Zip Code) (860) 226-6000 Registrant’s telephone number, including area code Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, Par Value $0.01 CI New York Stock Exchange , Inc.   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐         Item 8.01 Other Events. On January 31, 2024, The Cigna Group (“Cigna”) issued a press release announcing the entry into a share purchase agreement with Health Care Service Corporation (“HCSC”) pursuant to which, among other things, Cigna will sell to HCSC Cigna’s Medicare Advantage, Cigna Supplemental Benefits, Medicare Part D and CareAllies businesses for a total transaction value of approximately $3.7 billion. In connection with the transaction, Cigna will recognize an estimated pre-tax loss of $1.5 billion in net income as of December 31, 2023, which primarily represents asset write offs and costs to sell. The loss on sale will not affect adjusted income from op